Synergistic effect of bone morphogenetic proteins 2 and 7 by ex vivo gene therapy in a rat spinal fusion model

Journal of Bone and Joint Surgery

Volumn 95, Issue 17, 2013, Pages 1612-1619

  Kaito, Takashi ^a   Johnson, Jared ^b   Ellerman, Jessica ^b   Tian, Haijun ^b   Aydogan, Mehmet ^b   Chatsrinopkun, Mongkol ^b   Ngo, Stephanie ^b   Choi, Christine ^b   Wang, Jeffrey C ^b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; COLLAGEN SPONGE; ENHANCED GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; OSTEOGENIC PROTEIN 1; BMP2 PROTEIN, HUMAN; BMP7 PROTEIN, HUMAN;

ADIPOSE DERIVED STEM CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE REGENERATION; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUMBAR SPINE; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; OSSIFICATION; POSTERIOR SPINE FUSION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; SPINE RADIOGRAPHY; SURGICAL TECHNIQUE; X RAY FILM; ANIMAL; BONE DEVELOPMENT; DRUG EFFECT; GENE TRANSFER; GENETICS; LUMBAR VERTEBRA; METHODOLOGY; NUDE RAT; RADIOGRAPHY; SPINE FUSION; TREATMENT OUTCOME;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 7; BONE REGENERATION; GENE TRANSFER TECHNIQUES; HUMANS; LUMBAR VERTEBRAE; OSTEOGENESIS; RATS; RATS, NUDE; SPINAL FUSION; TREATMENT OUTCOME;

EID: 84887238671     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.L.01396     Document Type: Article

References (37)

1. Steinmann JC, Herkowitz HN. Pseudarthrosis of the spine. Clin Orthop Relat. Res. 1992 Nov;284: 80-90.
2. Zdeblick TA. A prospective, randomized study of lumbar fusion. Preliminary results. Spine (Phila Pa 1976) . 1993 Jun 15;18 (8) : 983-91.
3. Gupta MC, Maitra S. Bone grafts and bone morphogenetic proteins in spine fusion. Cell Tissue Bank. 2002;3 (4) : 255-67.
4. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA. Novel regulators of bone formation: molecular clones and activities. Science. 1988 Dec 16;242 (4885) : 1528-34.
5. Wang EA, Rosen V, D'Alessandro JS, Bauduy M, Cordes P, Harada T, Israel DI, Hewick RM, Kerns KM, LaPan P, et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci U S A. 1990 Mar;87 (6) : 2220-4.
6. Urist MR. Bone: formation by autoinduction. Science. 1965 Nov 12;150 (3698) : 893-9.
7. Gottfried ON, Dailey AT. Mesenchymal stem cell and gene therapies for spinal fusion. Neurosurgery. 2008 Sep;63 (3) : 380-91, discussion: 391-2.
8. Helm GA, Alden TD, Sheehan JP, Kallmes D. Bone morphogenetic proteins and bone morphogenetic protein gene therapy in neurological surgery: A review. Neurosurgery. 2000 May;46 (5) : 1213-22.
9. Wang JC, Kanim LE, Yoo S, Campbell PA, Berk AJ, Lieberman Jr. Effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats. J Bone Joint Surg Am. 2003 May;85 (5) : 905-11.
10. Riew KD, Wright NM, Cheng S, Avioli LV, Lou J. Induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene in a rabbit spinal fusion model. Calcif Tissue Int. 1998 Oct;63 (4) : 357-60.
11. Wozney JM, Rosen V, Celeste AJ,Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA. Novel regulators of bone formation: molecular clones and activities. Science. 1988 Dec 16;242 (4885) : 1528-34.
12. Cho TJ, Gerstenfeld LC, Einhorn TA. Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing. J Bone Miner Res. 2002 Mar;17 (3) : 513-20.
13. Israel DI, Nove J, Kerns KM, Kaufman RJ, Rosen V, Cox KA, Wozney JM. Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo. Growth Factors. 1996;13 (3-4) : 291-300.
14. Aono A, Hazama M, Notoya K, Taketomi S, Yamasaki H, Tsukuda R, Sasaki S, Fujisawa Y. Potent ectopic bone-inducing activity of bone morphogenetic protein-4/7 heterodimer. Biochem Biophys Res Commun. 1995 May 25;210 (3) : 670-7.
15. Hazama M, Aono A, Ueno N, Fujisawa Y. Efficient expression of a heterodimer of bone morphogenetic protein subunits using a baculovirus expression system. Biochem Biophys Res Commun. 1995 Apr 26;209 (3) : 859-66.
16. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002 Dec;13 (12) : 4279-95.
17. Qiao R, Zhou B, Harboe-Schmidt E, Kasahara N, Kim KJ, Liebler JM, Crandall ED, Borok Z. Subunit-specific coordinate upregulation of sodium pump activity in alveolar epithelial cells by lentivirus-mediated gene transfer. Hum Gene Ther. 2004 May;15 (5) : 457-68.
18. Naldini L, Blômer U, Gage FH, Trono D, Verma IM. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci U S A. 1996 Oct 15;93 (21) : 11382-8.
19. Sakoda T, Kasahara N, Hamamori Y, Kedes L. A high-titer lentiviral production system mediates efficient transduction of differentiated cells including beating cardiac myocytes. J Mol Cell Cardiol. 1999 Nov;31 (11) : 2037-47.
20. Miyazaki M, Sugiyama O, Zou J, Yoon SH, Wei F, Morishita Y, Sintuu C, Virk MS, Lieberman JR, Wang JC. Comparison of lentiviral and adenoviral gene therapy for spinal fusion in rats. Spine (Phila Pa 1976) . 2008 Jun 1;33 (13) : 1410-7.
21. Boden SD, Schimandle JH, Hutton WC. An experimental lumbar intertransverse process spinal fusion model. Radiographic, histologic, and biomechanical healing characteristics. Spine (Phila Pa 1976) . 1995 Feb 15;20 (4) : 412-20.
22. Zhu W, Rawlins BA, Boachie-Adjei O, Myers ER, Arimizu J, Choi E, Lieberman JR, Crystal RG, Hidaka C. Combined bone morphogenetic protein-2 and-7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model. J Bone Miner Res. 2004 Dec;19 (12) : 2021-32. Epub 2004 Aug 30.
23. Zhao M, Zhao Z, Koh JT, Jin T, Franceschi RT. Combinatorial gene therapy for bone regeneration: cooperative interactions between adenovirus vectors expressing bone morphogenetic proteins 2, 4, and 7. J Cell Biochem. 2005 May 1; 95 (1) : 1-16.
24. Hsu WK, Wang JC. The use of bone morphogenetic protein in spine fusion. Spine J. 2008 May-Jun;8 (3) : 419-25. Epub 2008 Apr 02.
25. Vaccaro AR, Whang PG, Patel T, Phillips FM, Anderson DG, Albert TJ, Hilibrand AS, Brower RS, Kurd MF, Appannagari A, Patel M, Fischgrund JS. The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study. Spine J. 2008 May-Jun;8 (3) : 457-65. Epub 2007 May 25.
26. Dimar JR, Glassman SD, Burkus KJ, Carreon LY. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft. Spine (Phila Pa 1976) . 2006 Oct 15;31 (22) : 2534-9, discussion: 2540.
27. Shields LB, Raque GH, Glassman SD, Campbell M, Vitaz T, Harpring J, Shields CB. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine (Phila Pa 1976) . 2006 Mar 1;31 (5) : 542-7.
28. Smucker JD, Rhee JM, Singh K, Yoon ST, Heller JG. Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine. Spine (Phila Pa 1976) . 2006 Nov 15;31 (24) : 2813-9.
29. Uludag H, D'Augusta D, Palmer R, Timony G, Wozney J. Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model. J Biomed Mater Res. 1999 Aug;46 (2) : 193-202.
30. Evans CH, Ghivizzani SC, Robbins PD. The 2003 Nicolas Andry Award. Orthopaedic gene therapy. Clin Orthop Relat Res. 2004 Dec;429: 316-29.
31. Nohe A, Keating E, Knaus P, Petersen NO. Signal transduction of bone morphogenetic protein receptors. Cell Signal. 2004 Mar;16 (3) : 291-9.
32. ten Dijke P, Yamashita H, Sampath TK, Reddi AH, EstevezM, Riddle DL, Ichijo H, Heldin CH, Miyazono K. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J Biol Chem. 1994 Jun 24;269 (25) : 16985-8.
33. Nishitoh H, Ichijo H, Kimura M, Matsumoto T, Makishima F, Yamaguchi A, Yamashita H, Enomoto S, Miyazono K. Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5. J Biol Chem. 1996 Aug 30;271 (35) : 21345-52.
34. Yamashita H, ten Dijke P, Huylebroeck D, Sampath TK, Andries M, Smith JC, Heldin CH, Miyazono K. Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects. J Cell Biol. 1995 Jul;130 (1) : 217-26.
35. Isaacs MJ, Kawakami Y, Allendorph GP, Yoon BH, Izpisua Belmonte JC, Choe S. Bone morphogenetic protein-2 and-6 heterodimer illustrates the nature of ligandreceptor assembly. Mol Endocrinol. 2010 Jul;24 (7) : 1469-77. Epub 2010 May 19.
36. Valera E, Isaacs MJ, Kawakami Y, Izpis'ua Belmonte JC, Choe S. BMP-2/6 heterodimer is more effective than BMP-2 or BMP-6 homodimers as inductor of differentiation of human embryonic stem cells. PLoS One. 2010;5 (6) : e11167. Epub 2010 Jun 17.
37. Zhu W, Kim J, Cheng C, Rawlins BA, Boachie-Adjei O, Crystal RG, Hidaka C. Noggin regulation of bone morphogenetic protein (BMP) 2/7 heterodimer activity in vitro. Bone. 2006 Jul;39 (1) : 61-71. Epub 2006 Feb 20.